본문

Baegen

Bio  Pharmaceuticals  
Developing a synthetic new drug to treat Chronic Obstructive Pulmonary Disease (COPD)

Baegen has isolated and synthesized BG-519 — a treatment for Chronic Obstructive Pulmonary Disease (COPD) — from the traditional Korean herbal formula 'Bodohwan'. The company is developing a treatment with superior efficacy and a proven safety profile in the human body for COPD patients who have long suffered from the absence of a fundamental cure.

Category
Bio, Pharmaceuticals
Status
Active
Founded
2021
Location
Korea
CEO
배준
Related Video

관련자료